Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.
Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.
复制标题
DOI:
10.1371/journal.ppat.1000826
复制
发表时间:
2010-03-26
期刊:
影响因子:
6.7
通讯作者:
Pier GB
中科院分区:
文献类型:
--
作者:
Gadjeva M;Nagashima J;Zaidi T;Mitchell RA;Pier GB
Pseudomonas aeruginosa causes severe sight-threatening corneal infections, with the inflammatory response to the pathogen being the major factor resulting in damage to the cornea that leads to loss of visual acuity. We found that mice deficient for macrophage migration inhibitory factor (MIF), a key regulator of inflammation, had significantly reduced consequences from acute P. aeruginosa keratitis. This improvement in the outcome was manifested as improved bacterial clearance, decreased neutrophil infiltration, and decreased inflammatory responses when P. aeruginosa-infected MIF knock out (KO) mice were compared to infected wild-type mice. Recombinant MIF applied to infected corneas restored the susceptibility of MIF deficient mice to P. aeruginosa-induced disease, demonstrating that MIF is necessary and sufficient to cause significant pathology at this immune privileged site. A MIF inhibitor administered during P. aeruginosa-induced infection ameliorated the disease-associated pathology. MIF regulated epithelial cell responses to infection by enhancing synthesis of proinflammatory mediators in response to P. aeruginosa infection and by promoting bacterial invasion of corneal epithelial cells, a correlate of virulence in the keratitis model. Our results uncover a host factor that elevates inflammation and propagates bacterial cellular invasion, and further suggest that inhibition of MIF during infection may have a beneficial therapeutic effect. Pseudomonas aeruginosa can induce infections that lead to a rapid loss of visual function. The current therapy includes antibiotic treatment which reduces the bacterial burden; nevertheless, tissue damage occurs as a result of an uncontrolled inflammation. Therefore, new therapeutic approaches are needed that will combine antimicrobial treatment with anti-inflammatory treatment. Our experiments have uncovered that mice deficient for macrophage migration inhibitory factor (MIF) recovered from acute bacterial infection more efficiently than wild-type control mice. This improvement was manifested as improved bacterial clearance, and decreased inflammatory responses in the MIF knockouts when compared to P. aeruginosa-infected wild-type control mice. We find that treatment of the infected mice with small molecule inhibitor of MIF activity after the onset of the infection promoted recovery from disease. This approach will facilitate generation of novel treatment strategies for bacterial keratitis.
登录
查看更多内容
影响因子:
3.3
作者:
Matsuda, A;Tagawa, Y;Nishihira, J
通讯作者:
Nishihira, J
影响因子:
3.1
作者:
Hazlett, LD
通讯作者:
Hazlett, LD
影响因子:
3.5
作者:
Matsuda, A;Tagawa, Y;Nishihira, J
通讯作者:
Nishihira, J
影响因子:
3.1
作者:
Thakur, A;Xue, M;Willcox, MDP
通讯作者:
Willcox, MDP
影响因子:
2
作者:
Miyazaki, D;Inoue, Y;Hayashi, K
通讯作者:
Hayashi, K